vs

Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Princeton Bancorp, Inc. (BPRN). Click either name above to swap in a different company.

Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $20.7M, roughly 1.0× Princeton Bancorp, Inc.). Princeton Bancorp, Inc. runs the higher net margin — 29.3% vs -373.3%, a 402.6% gap on every dollar of revenue. Princeton Bancorp, Inc. produced more free cash flow last quarter ($20.6M vs $-72.3M).

Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.

Princeton Bancorp, Inc. is a U.S.-based bank holding company operating through its community banking subsidiary. It offers retail and commercial banking products including deposit accounts, small business loans, consumer loans, mortgages and wealth management services, primarily serving clients across New Jersey and the U.S. mid-Atlantic region.

AUTL vs BPRN — Head-to-Head

Bigger by revenue
AUTL
AUTL
1.0× larger
AUTL
$21.2M
$20.7M
BPRN
Higher net margin
BPRN
BPRN
402.6% more per $
BPRN
29.3%
-373.3%
AUTL
More free cash flow
BPRN
BPRN
$92.9M more FCF
BPRN
$20.6M
$-72.3M
AUTL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
AUTL
AUTL
BPRN
BPRN
Revenue
$21.2M
$20.7M
Net Profit
$-79.1M
$6.1M
Gross Margin
Operating Margin
-337.9%
38.2%
Net Margin
-373.3%
29.3%
Revenue YoY
3.6%
Net Profit YoY
3.6%
16.3%
EPS (diluted)
$-0.30
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUTL
AUTL
BPRN
BPRN
Q4 25
$20.7M
Q3 25
$21.2M
$21.5M
Q2 25
$20.9M
$21.1M
Q1 25
$9.0M
$20.9M
Q4 24
$20.0M
Q3 24
$0
$19.2M
Q2 24
$0
$18.1M
Q1 24
$10.1M
$17.4M
Net Profit
AUTL
AUTL
BPRN
BPRN
Q4 25
$6.1M
Q3 25
$-79.1M
$6.5M
Q2 25
$-47.9M
$688.0K
Q1 25
$-70.2M
$5.4M
Q4 24
$5.2M
Q3 24
$-82.1M
$-4.5M
Q2 24
$-58.3M
$5.1M
Q1 24
$-52.7M
$4.3M
Operating Margin
AUTL
AUTL
BPRN
BPRN
Q4 25
38.2%
Q3 25
-337.9%
38.5%
Q2 25
-292.6%
2.8%
Q1 25
-726.3%
32.9%
Q4 24
34.0%
Q3 24
-29.1%
Q2 24
34.1%
Q1 24
-384.1%
31.0%
Net Margin
AUTL
AUTL
BPRN
BPRN
Q4 25
29.3%
Q3 25
-373.3%
30.0%
Q2 25
-229.0%
3.3%
Q1 25
-781.1%
25.7%
Q4 24
26.1%
Q3 24
-23.3%
Q2 24
28.4%
Q1 24
-522.1%
24.9%
EPS (diluted)
AUTL
AUTL
BPRN
BPRN
Q4 25
$0.89
Q3 25
$-0.30
$0.95
Q2 25
$-0.18
$0.10
Q1 25
$-0.26
$0.77
Q4 24
$0.75
Q3 24
$-0.31
$-0.68
Q2 24
$-0.22
$0.80
Q1 24
$-0.24
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUTL
AUTL
BPRN
BPRN
Cash + ST InvestmentsLiquidity on hand
$86.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$265.5M
$270.7M
Total Assets
$661.9M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUTL
AUTL
BPRN
BPRN
Q4 25
Q3 25
$86.1M
Q2 25
$123.8M
Q1 25
$95.8M
Q4 24
Q3 24
$657.1M
Q2 24
$705.9M
Q1 24
$758.5M
Total Debt
AUTL
AUTL
BPRN
BPRN
Q4 25
Q3 25
$0
Q2 25
$10.0M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AUTL
AUTL
BPRN
BPRN
Q4 25
$270.7M
Q3 25
$265.5M
$266.6M
Q2 25
$346.5M
$261.9M
Q1 25
$371.1M
$267.0M
Q4 24
$262.0M
Q3 24
$477.0M
$261.5M
Q2 24
$527.8M
$244.8M
Q1 24
$582.0M
$241.8M
Total Assets
AUTL
AUTL
BPRN
BPRN
Q4 25
$2.3B
Q3 25
$661.9M
$2.2B
Q2 25
$721.0M
$2.2B
Q1 25
$746.3M
$2.3B
Q4 24
$2.3B
Q3 24
$827.5M
$2.4B
Q2 24
$853.6M
$2.0B
Q1 24
$901.4M
$2.0B
Debt / Equity
AUTL
AUTL
BPRN
BPRN
Q4 25
Q3 25
0.00×
Q2 25
0.04×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUTL
AUTL
BPRN
BPRN
Operating Cash FlowLast quarter
$-67.9M
$21.5M
Free Cash FlowOCF − Capex
$-72.3M
$20.6M
FCF MarginFCF / Revenue
-341.2%
99.3%
Capex IntensityCapex / Revenue
20.8%
4.3%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$-322.5M
$29.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUTL
AUTL
BPRN
BPRN
Q4 25
$21.5M
Q3 25
$-67.9M
$4.9M
Q2 25
$-72.8M
$3.1M
Q1 25
$-75.6M
$1.3M
Q4 24
$14.7M
Q3 24
$-76.7M
$1.2M
Q2 24
$-51.1M
$4.3M
Q1 24
$-40.5M
$4.8M
Free Cash Flow
AUTL
AUTL
BPRN
BPRN
Q4 25
$20.6M
Q3 25
$-72.3M
$4.7M
Q2 25
$-80.1M
$2.9M
Q1 25
$-83.8M
$1.1M
Q4 24
$13.2M
Q3 24
$-86.3M
$766.0K
Q2 24
$-51.9M
$3.9M
Q1 24
$-41.0M
$4.8M
FCF Margin
AUTL
AUTL
BPRN
BPRN
Q4 25
99.3%
Q3 25
-341.2%
21.6%
Q2 25
-382.6%
13.7%
Q1 25
-933.1%
5.0%
Q4 24
65.9%
Q3 24
4.0%
Q2 24
21.8%
Q1 24
-406.8%
27.3%
Capex Intensity
AUTL
AUTL
BPRN
BPRN
Q4 25
4.3%
Q3 25
20.8%
1.1%
Q2 25
34.8%
1.2%
Q1 25
91.8%
1.0%
Q4 24
7.6%
Q3 24
2.2%
Q2 24
2.1%
Q1 24
5.3%
0.4%
Cash Conversion
AUTL
AUTL
BPRN
BPRN
Q4 25
3.54×
Q3 25
0.76×
Q2 25
4.57×
Q1 25
0.23×
Q4 24
2.82×
Q3 24
Q2 24
0.84×
Q1 24
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons